These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cell proliferation in human epiretinal membranes: characterization of cell types and correlation with disease condition and duration. Oberstein SY; Byun J; Herrera D; Chapin EA; Fisher SK; Lewis GP Mol Vis; 2011; 17():1794-805. PubMed ID: 21750605 [TBL] [Abstract][Full Text] [Related]
6. Single-Cell Protein and Transcriptional Characterization of Epiretinal Membranes From Patients With Proliferative Vitreoretinopathy. Laich Y; Wolf J; Hajdu RI; Schlecht A; Bucher F; Pauleikhoff L; Busch M; Martin G; Faatz H; Killmer S; Bengsch B; Stahl A; Lommatzsch A; Schlunck G; Agostini H; Boneva S; Lange C Invest Ophthalmol Vis Sci; 2022 May; 63(5):17. PubMed ID: 35579905 [TBL] [Abstract][Full Text] [Related]
7. Elucidation of the pathogenic mechanism of rhegmatogenous retinal detachment with proliferative vitreoretinopathy by proteomic analysis. Yu J; Peng R; Chen H; Cui C; Ba J Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8146-53. PubMed ID: 23139279 [TBL] [Abstract][Full Text] [Related]
8. Risk factors for epiretinal membrane in eyes with primary rhegmatogenous retinal detachment that received silicone oil tamponade. Pan Q; Gao Z; Hu X; Wu Q; Zheng JW; Zhang ZD Br J Ophthalmol; 2023 Jun; 107(6):856-861. PubMed ID: 35184034 [TBL] [Abstract][Full Text] [Related]
9. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy. Roldán-Pallarés M; Rollín R; Mediero A; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R Mol Vis; 2005 Jul; 11():461-71. PubMed ID: 16030497 [TBL] [Abstract][Full Text] [Related]
10. Immunological biomarkers of the vitreous responsible for proliferative alteration in the different forms of retinal detachment. Balogh A; Milibák T; Szabó V; Nagy ZZ; Kaarniranta K; Resch MD BMC Ophthalmol; 2020 Dec; 20(1):491. PubMed ID: 33371882 [TBL] [Abstract][Full Text] [Related]
11. Vitreous levels of Lipocalin-2 on patients with primary rhegmatogenous retinal detachment. Batsos G; Christodoulou E; Vartholomatos G; Galanis P; Stefaniotou M PLoS One; 2019; 14(12):e0227266. PubMed ID: 31891637 [TBL] [Abstract][Full Text] [Related]
12. Comparison of gene expression profile of epiretinal membranes obtained from eyes with proliferative vitreoretinopathy to that of secondary epiretinal membranes. Asato R; Yoshida S; Ogura A; Nakama T; Ishikawa K; Nakao S; Sassa Y; Enaida H; Oshima Y; Ikeo K; Gojobori T; Kono T; Ishibashi T PLoS One; 2013; 8(1):e54191. PubMed ID: 23372684 [TBL] [Abstract][Full Text] [Related]
13. Vitreous M2 Macrophage-Derived Microparticles Promote RPE Cell Proliferation and Migration in Traumatic Proliferative Vitreoretinopathy. Song Y; Liao M; Zhao X; Han H; Dong X; Wang X; Du M; Yan H Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):26. PubMed ID: 34554178 [TBL] [Abstract][Full Text] [Related]
14. Risk of Tertiary, Quaternary, and Quinary Proliferative Vitreoretinopathy: Analysis of a Nationwide Database (2010-2017). Aziz K; Patel T; Canner JK; Swenor BK; Singh MS Ophthalmol Retina; 2023 Jun; 7(6):489-495. PubMed ID: 36717076 [TBL] [Abstract][Full Text] [Related]
15. [Proliferative vitreoretinopathy (PVR) surgery: Scar Wars : Five steps to successful treatment of PVR detachment]. Priglinger SG; Siedlecki J; Hattenbach LO; Grisanti S Ophthalmologe; 2021 Jan; 118(1):18-23. PubMed ID: 33346893 [TBL] [Abstract][Full Text] [Related]
16. The upregulation of zinc finger protein 670 and prostaglandin D2 synthase in proliferative vitreoretinopathy. Kuo HK; Chen YH; Huang F; Wu YC; Shiea J; Wu PC Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):205-13. PubMed ID: 25940552 [TBL] [Abstract][Full Text] [Related]
17. Rhegmatogenous retinal detachment and conventional surgical treatment. Golubovic M Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2013; 34(1):161-6. PubMed ID: 23917750 [TBL] [Abstract][Full Text] [Related]
18. A brief review of the histopathology of proliferative vitreoretinopathy (PVR). Mudhar HS Eye (Lond); 2020 Feb; 34(2):246-250. PubMed ID: 31792351 [TBL] [Abstract][Full Text] [Related]
19. [Proliferative vitreoretinopathy (PVR) minimal: same, same but different. Characteristics and surgical treatment of PVR-associated macular pucker]. Hattenbach LO; Grisanti S; Priglinger SG; Chronopoulos A Ophthalmologe; 2021 Jan; 118(1):24-29. PubMed ID: 33336260 [TBL] [Abstract][Full Text] [Related]
20. Induction of proliferative vitreoretinopathy by a unique line of human retinal pigment epithelial cells. Wong CA; Potter MJ; Cui JZ; Chang TS; Ma P; Maberley AL; Ross WH; White VA; Samad A; Jia W; Hornan D; Matsubara JA Can J Ophthalmol; 2002 Jun; 37(4):211-20. PubMed ID: 12095094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]